Archive for 2004
The Stem Cell Gold Rush
The Stem Cell Gold Rush:
Scientists around the country who study embryonic stem cells may be mourning four more years of President Bush’s restrictive funding policy, but California scientists are throwing a party, and top researchers in less-funded states are hoping for invitations.
Financial Snapshot For September 2004
Financial Snapshot For September 2004
In need of a boost.
Biotech: The “safe” drug bet?
Biotech: The “safe” drug bet?
“Defensive pharma stocks have struggled while biotechs have flourished. Can this continue?”
Biotech execs have a sense of humor about elusive profits
Biotech execs have a sense of humor about elusive profits
When Ernst & Young’s annual report on the biotechnology industry last year predicted that as a whole, the industry would turn profitable for the first time in 2008, some long-term industry veterans gave a knowing heard-that-one-before chuckle.
Is That a Pilot in Your Pocket?
Is That a Pilot in Your Pocket?
“Somewhere in Florida, 25,000 disembodied rat neurons are thinking about flying an F-22. “
Foresight or folly? Generics firms’ foray into NCEs
Foresight or folly? Generics firms’ foray into NCEs
A number of generics firms have, over the last few years, veered off the path and started to develop innovative drugs in their own right. In a time when generics firms are showing the greatest growth in the pharmaceutical sector, what has driven them to venture into new [...]
